Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-003732
Filing Date
2023-05-30
Accepted
2023-05-30 08:04:16
Documents
39
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q taihe_10q-313123.htm   iXBRL 10-Q 273634
2 CERTIFICATION taihe_ex3101.htm EX-31.1 9269
3 CERTIFICATION taihe_ex3102.htm EX-31.2 9536
4 CERTIFICATION taihe_ex3201.htm EX-32.1 3681
5 CERTIFICATION taihe_ex3202.htm EX-32.2 3924
  Complete submission text file 0001683168-23-003732.txt   1678035

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tihe-20230331.xsd EX-101.SCH 13176
7 XBRL CALCULATION FILE tihe-20230331_cal.xml EX-101.CAL 21816
8 XBRL DEFINITION FILE tihe-20230331_def.xml EX-101.DEF 29905
9 XBRL LABEL FILE tihe-20230331_lab.xml EX-101.LAB 126492
10 XBRL PRESENTATION FILE tihe-20230331_pre.xml EX-101.PRE 95728
33 EXTRACTED XBRL INSTANCE DOCUMENT taihe_10q-313123_htm.xml XML 135505
Mailing Address INDONESIAN STREET CITY, JL. BATU LICIN, BINTAN ISLAND KEPULAUAN RIAU K8 29151
Business Address INDONESIAN STREET CITY, JL. BATU LICIN, BINTAN ISLAND KEPULAUAN RIAU K8 29151 86-21-5091-7695
Taihe Group, Inc. (Filer) CIK: 0001066719 (see all company filings)

EIN.: 650019376 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26113 | Film No.: 23971489
SIC: 8071 Services-Medical Laboratories